NattoPharma ASA announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was NOK 48.383 million compared to NOK 29.996 million a year ago. Operating income was NOK 1.878 million compared to operating loss of NOK 1.534 million a year ago. Net income was NOK 23.189 million compared to net loss of NOK 1.252 million a year ago. Basic earnings per share was NOK 1.23 compared to basic loss per share of NOK 0.07 a year ago. Diluted earnings per share was NOK 1.16 compared to diluted loss per share of NOK 0.07 a year ago. For the half year, sales was NOK 104.648 million compared to NOK 57.767 million a year ago. Operating income was NOK 9.977 million compared to operating loss of NOK 2.031 million a year ago. Net income was NOK 33.058 million compared to net loss of NOK 1.445 million a year ago. Basic earnings per share was NOK 1.76 compared to basic loss per share of NOK 0.08 a year ago. Diluted earnings per share was NOK 1.66 compared to diluted loss per share of NOK 0.08 a year ago.